Lawrence He
SVP, Global Regulatory Head
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Lawrence He as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:11 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04795141 · ABY-035 in the Treatment of Subjects With Ankylosing SpondylitisInmagene LLC · terminated · Ankylosing Spondylitis · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 77 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:11 UTC. The ranking covers the 200 most relevant of 500 PubMed records, and a shared surname and initials can bring in a namesake. All 500 on PubMed
- 294 citationsRCR 14.4
- Acupuncture for Chronic Severe Functional Constipation: A Randomized Trial.Ann Intern Med · 2016215 citationsRCR 10.2
- MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer.Cancer Discov · 2023209 citationsRCR 15.8
- Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma.N Engl J Med · 2024176 citationsRCR 20.7
- Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial.JAMA Neurol · 2023134 citationsRCR 15.9
- Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients.Clin Cancer Res · 2011116 citationsRCR 2.7
- Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis.Thromb Haemost · 2015106 citationsRCR 4.6
- 105 citationsRCR 38.4
- Efficacy of Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome : A Randomized Trial.Ann Intern Med · 202195 citationsRCR 7.2
- EROSION III: A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency.JACC Cardiovasc Interv · 202286 citationsRCR 6.3